← Back to Clinical Trials
Recruiting NCT06373965

NCT06373965 Integrated Online-to-offline (O2O) Model of Care for HIV Prevention and Treatment Among Transgender Women (CINTAI)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06373965
Status Recruiting
Phase
Sponsor University of Connecticut
Condition HIV Prevention Program
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2024-08-13
Primary Completion 2025-12-06

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Online to offline counseling

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2024-08-13 with a primary completion date of 2025-12-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The proposed research focuses on developing and testing a web-based platform, called Jom-TestPlus, that will incorporate HIV self-testing (HIVST) with real-time e-counseling (eHIVST) with online-to-offline (O2O) linkage to HIV prevention and treatment services while simultaneously co-addressing chemsex-related needs for transgender women (TGW) in Malaysia. This model represents a potentially impactful strategy for reaching marginalized populations, like TGW, and allows immediate engagement in the post-test linkage process to prevention or treatment services.

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years; * Cisgender male; * HIV-negative or HIV status unknown; * Own or have access to a computer, tablet, or internet-enabled smartphone Exclusion Criteria: * Currently on PrEP * Unable to provide informed consent * Unable to read and understand English or Bahasa Malaysia

Contact & Investigator

Central Contact

Roman Shrestha

✉ roman.shrestha@uconn.edu

📞 8604862446

Frequently Asked Questions

Who can join the NCT06373965 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying HIV Prevention Program. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06373965 currently recruiting?

Yes, NCT06373965 is actively recruiting participants. Contact the research team at roman.shrestha@uconn.edu for enrollment information.

Where is the NCT06373965 trial being conducted?

This trial is being conducted at Kuala Lumpur, Malaysia, Kuala Lumpur, Malaysia.

Who is sponsoring the NCT06373965 clinical trial?

NCT06373965 is sponsored by University of Connecticut. The trial plans to enroll 50 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology